Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (269)	3/23/1998 4:45:00 PM
From: SnowShredder	Read Replies (1) \| Respond to of 4474

Dr.Anderson is director of Gene Therapy Laboratories and a professor @ USC. He was the head of NIH for a # of years and is the editor-in-chief of Human Gene Therapy. I believe that he was one of the 1st to use the techniques of exvivo gene therapy (taking cells from the body, infecting them with virus, putting the infected/transduced cells back into the body). Basically, he is a big wig in the field. I think he founded GTI...which was bought out by Novartis. @ the conference he basically said that he was going to pursue the goal of being a pioneer in inutero gene therapy. I hope this helps. Best of luck, Where'd He Go?